The invention relates to vulnerable plaque detection, and in particular, to catheters used to detect vulnerable plaque.
Atherosclerosis is a vascular disease characterized by a modification of the walls of blood-carrying vessels. Such modifications, when they occur at discrete locations or pockets of diseased vessels, are referred to as plaques. Certain types of plaques are associated with acute events such as stroke or myocardial infarction. These plaques are referred to as “vulnerable plaques.” A vulnerable plaque typically includes a lipid-containing pool separated from the blood by a thin fibrous cap. In response to elevated intraluminal pressure or vasospasm, the fibrous cap can become disrupted, exposing the contents of the plaque to the flowing blood. The resulting thrombus can lead to ischemia or to the shedding of emboli.
One method of locating vulnerable plaque is to peer through the arterial wall with infrared light. To do so, one inserts a catheter through the lumen of the artery. The catheter includes a delivery fiber for illuminating a spot on the arterial wall with infrared light. A portion of the light penetrates the blood and arterial wall, scatters off structures within the wall and re-enters the lumen. This re-entrant light can be collected by a collection fiber within the catheter and subjected to spectroscopic analysis. This type of diffuse reflectance spectroscopy can be used to determine chemical composition of arterial tissue, including key constituents believed to be associated with vulnerable plaque such as lipid content.
Another method of locating vulnerable plaque is to use intravascular ultrasound (IVUS) to detect the shape of the arterial tissue surrounding the lumen. To use this method, one also inserts a catheter through the lumen of the artery. The catheter includes an ultrasound transducer to send ultrasound energy towards the arterial wall. The reflected ultrasound energy is received by the ultrasound transducer and is used to map the shape of the arterial tissue. This map of the morphology of the arterial wall can be used to detect the fibrous cap associated with vulnerable plaque.
The invention arises in an effort to overcome noise and electromagnetic interference associated with transport of RF energy across a slip-ring that interfaces a spinning portion of a catheter with stationary elements that generate and/or process the RF energy.
In one aspect, the invention features an apparatus for detecting vulnerable plaque in a blood vessel. The apparatus includes an intravascular probe having proximal and distal ends. A slip ring having a stationary portion and a spinning portion is at the proximal end. An ultrasound transceiver board is mechanically coupled to the spinning portion of the slip ring for communication with an ultrasound transducer, also within the probe. A transmission line extends between the ultrasound transducer and the ultrasound transceiver board.
In some embodiments, the apparatus also includes a pair of optical fibers extending distally from the proximal end of the probe; and an optical bench for receiving the optical fibers.
In other embodiments, the transceiver board includes an RF circuit for providing RF energy to the ultrasound transducer, and for receiving RF energy and extracting information therefrom.
Other embodiments includes those in which a power supply is coupled to the stationary portion of the slip ring for providing power to the RF circuit on the ultrasound transceiver board, and those in which a processor is coupled to the stationary portion of the slip ring for receiving data from the ultrasound transceiver board.
In another aspect, the invention features a method for detecting vulnerable plaque. The method includes inserting a catheter containing an ultrasound transducer into a blood vessel; spinning the ultrasound transducer within the catheter; and concurrent with spinning the ultrasound transducer, spinning a source of RF energy for the ultrasonic transducer.
In some practices, the method also includes coupling power from a power source to the source of RF energy, with the power source being one that can rotate relative to the source of RF power for the ultrasound transducer. Typically, relative rotation would include having the power source be in a stationary reference frame and having the catheter rotate, so that if one viewed the power source from the rotating reference frame of the catheter, it would appear to be rotating. Such coupling of power can include coupling power from a power source to the source of RF power coupling power across a slip ring.
In yet other practices, the method includes receiving a signal from the ultrasound transducer; extracting information from the received signal; encoding the extracted information onto a digital signal; and coupling the digital signal to a processor that rotates relative to the ultrasound transducer.
As used herein, “infrared” means infrared, near infrared, intermediate infrared, far infrared, or extreme infrared.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described below. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.
Other features and advantages of the invention will be apparent from the following detailed description, the claims, and the following figures, in which:
The vulnerability of a plaque to rupture can be assessed by detecting a combination of attributes such as macrophage presence, local temperature rise, and a lipid-rich pool covered by a thin fibrous cap. Some detection modalities are only suited to detecting one of these attributes.
Referring to
A delivery fiber 122 and a collection fiber 123 extend between proximal and distal ends of the catheter 112. An optical bench 118 holds the distal ends of both the collection fiber 123 and the delivery fiber 122. A housing 116 is located at the distal end of the catheter 112 houses both the optical bench 118 and one or more ultrasound transducers 120.
A light source (not shown) couples light into a proximal end of the delivery fiber 122. The delivery fiber guides this light to a delivery mirror 124 on the optical bench 118, which redirects the light 125 towards the arterial wall 104. A collection mirror 126, also on the optical bench 118, redirects light 127 scattered from various depths of the arterial wall 104 into the distal end of the collection fiber 123. Other beam redirectors can be used in place of delivery mirror 124 and collection mirror 126 (e.g., a prism or a bend in the optical fiber tip).
A proximal end of collection fiber 123 is in optical communication with an optical detector (not shown). The optical detector produces an electrical signal that contains a spectral signature indicating the composition of the arterial wall 104, and in particular, whether the composition is consistent with the presence of lipids found in a vulnerable plaque 102. The spectral signature in the electrical signal can be analyzed using a spectrum analyzer (not shown) implemented in hardware, software, or a combination thereof.
Alternatively, in an implementation shown in
The ultrasound transducer 120, which is longitudinally adjacent to the optical bench 118, directs ultrasound energy 130 towards the arterial wall 104, and receives ultrasound energy 132 reflected from the arterial wall 104. Using time multiplexing, the ultrasound transducer 120 can couple both the transmitted 130 and received 132 ultrasound energy to an electrical signal carried on a transmission line 128. For example, during a first time interval, an electrical signal carried on the transmission line 128 causes the ultrasound transducer 120 to emit a corresponding ultrasound signal. Then during a second time interval, after the ultrasound signal has reflected from the arterial wall, the ultrasound transducer 120 produces an electrical signal carried on the transmission line 128. This electrical signal corresponds to the received ultrasound signal. The received electrical signal can be used to reconstruct the shape of the arterial wall, including cap thickness of any plaque 102 detected therein.
In some embodiments, multiple ultrasound transducers 120 are mounted adjacent to the optical bench 118. These multiple transducers are oriented to concurrently illuminate different circumferential angles. An advantage of such a configuration is that one can obtain the same resolution at a lower spin rate as a single transducer embodiment could achieve at a higher spin rate.
The signals carried on the transmission line 128 propagate between the transducer 120 and an RF circuit 129 mounted on an ultrasound transceiver board 131 at the proximal end of the catheter 112, as shown in
Referring back to
Referring back to
Following transmission of a pulse, the control logic 217 switches the T/R switch 241 from transmit mode into receive mode, thereby making an echo signal available to the receiving portion 213.
The receiving portion 213 includes a signal conditioning unit 235 for receiving an RF signal from the transmission line 128 and transforming that signal into a form suitable for processing by an A/D converter 237 in electrical communication with the signal conditioning unit 235. Typical operations carried out by the signal conditioning unit 235 include amplification and filtering operations. The parameters associated with operations carried out by the signal conditioning unit 235 are provided by control signals from the control logic 217. Such control signals include signals specifying gain, compensation, and clock pulses.
The receiving portion 213 also includes a communication interface 239 for receiving digital signals from the A/D converter 237 and providing those signals to the processor 143. The receiving portion 213 also includes a digital signal processor 243 for further processing the signal received from the A/D converter 237. The additional signal processing steps can include additional filtering, decimation, ring-down suppression, and envelope detection. The resulting decimated data, which can be as much as two orders of magnitude less than the original data, is then provided to a communication interface 239 for transmission to the external processor using conventional communication protocols.
The stationary portion 138 of the slip ring 137 is coupled to a power supply 141 that provides power to the spinning RF circuit 129. The configuration shown in
Inside the sheath 114 is a transmission medium 134, such as saline or other fluid, surrounding the ultrasound transducer 120 for improved acoustic transmission. The transmission medium 134 is also transparent to the infrared light emitted from the optical bench 118.
A torque cable 126 attached to the housing 116 surrounds the optical fibers 122 and the wires 128. A motor (not shown) rotates the torque cable 126, thereby causing the housing 116 to rotate. This feature enables the intravascular probe 100 to circumferentially scan the arterial wall 104 with light 124 and ultrasound energy 130.
During operation, the intravascular probe 100 is inserted along a blood vessel, typically an artery, using the guidewire 108. In one practice the intravascular probe 100 is inserted in discrete steps with a complete rotation occurring at each such step. In this case, the optical and ultrasound data can be collected along discrete circular paths. Alternatively, the intravascular probe 100 is inserted continuously, with axial translation and rotation occurring simultaneously. In this case, the optical and ultrasound data are collected along continuous helical paths. In either case, the collected optical data can be used to generate a three-dimensional spectral map of the arterial wall 104, and the collected ultrasound data can be used to generate a three-dimensional morphological map of the arterial wall 104. A correspondence is then made between the optical and ultrasound data based on the relative positions of the optical bench 118 and the ultrasound transducer 120. The collected data can be used in real-time to diagnose vulnerable plaques, or identify other lesion types which have properties that can be identified by these two detection modalities, as the intravascular probe 100 traverses an artery. The intravascular probe 100 can optionally include structures for carrying out other diagnostic or treatment modalities in addition to the infrared spectroscopy and IVUS diagnostic modalities.
The intravascular probe 500 can collect data simultaneously in all radial directions thereby enhancing speed of diagnosis. Or, the intravascular probe 500 can collect data from different locations at different times, to reduce potential crosstalk due to light being collected by neighboring optical fibers or ultrasound energy being collected by neighboring transducers. The radial resolution of spectral and/or morphological maps will be lower than the maps created in the embodiments with rotating cores, although the extent of this difference in resolution will depend on the number of optical fibers and ultrasound transducers. A large number of optical fibers and/or ultrasound transducers, while increasing the radial resolution, could also make the intravascular probe 500 too large to fit in some blood vessels.
Intravascular probe 500 can be inserted through a blood vessel along a guidewire 508 that passes through a concentric guidewire lumen 510. Inserting a catheter using a concentric guidewire lumen 510 has advantages over using an off-axis distal guidewire lumen 110. One advantage is that the guidewire 508 has a smaller chance of becoming tangled. Another advantage is that, since a user supplies a load that is coaxial to the wire during insertion, the concentric guidewire lumen 510 provides better trackability. The concentric guidewire lumen 510 also removes the guidewire 508 from the field of view of the optical fibers and ultrasound transducers.
The intravascular probes include a catheter having a diameter small enough to allow insertion of the probe into small blood vessels.
The rotating core catheter 660, shown in
The fixed core catheter 670, shown in
It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.
This application is a non-provisional claiming the benefit of the priority date of U.S. Application No. 61/007,515, filed May 7, 2008, the contents of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
61007515 | May 2008 | US |